Inhibitory effects of phenolic compounds on development of naturally occurring preneoplastic hepatocytic foci in long-term feeding studies using male F344 rats. 1996

A Hagiwara, and Y Kokubo, and Y Takesada, and H Tanaka, and S Tamano, and M Hirose, and T Shirai, and N Ito
Daiyu-kai Institute of Medical Science, Ichinomiya, Japan.

Five phenolic compounds, namely caffeic acid, sesamol, hydroquinone, catechol, and 4-methoxyphenol, were fed to groups of 30 male F344 rats at dietary levels of 2, 2, 0.3, 0.8, and 2%, respectively, for 2 years. Retardation of body weight and elevated relative liver weights were noted for all groups. Formalin-fixed and paraffin-embedded liver tissues from rats killed terminally were cut and stained for glutathione S-transferase placental form (GST-P) and tumor growth factor alpha (TGF alpha) immunohistochemically. Numbers and areas of GST-P-positive (GST-P+) foci per unit area of liver section were measured, and the respective treated/control proportional values were calculated to be 58 and 57% for caffeic acid. 58 and 54% for sesamol, 71 and 71% for hydroquinone. 58 and 133% for catechol, and 49 and 39% for 4-methoxyphenol. These data were comparable with results obtained with medium-term liver bioassays (Ito test). However, no intergroup differences were detected with regard to quantitative findings for TGF alpha foci, which were relatively rare. Long-term inhibitory effects of phenolic compounds on liver carcinogenesis, predicted from the Ito test, were thus confirmed in the present feeding studies using quantitative analysis of immunohistochemically demonstrable GST-P+ foci as end point marker lesions.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008114 Liver Neoplasms, Experimental Experimentally induced tumors of the LIVER. Hepatoma, Experimental,Hepatoma, Morris,Hepatoma, Novikoff,Experimental Hepatoma,Experimental Hepatomas,Experimental Liver Neoplasms,Hepatomas, Experimental,Neoplasms, Experimental Liver,Experimental Liver Neoplasm,Liver Neoplasm, Experimental,Morris Hepatoma,Novikoff Hepatoma
D008297 Male Males
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D010636 Phenols Benzene derivatives that include one or more hydroxyl groups attached to the ring structure.
D011230 Precancerous Conditions Pathological conditions that tend eventually to become malignant. Preneoplastic Conditions,Condition, Preneoplastic,Conditions, Preneoplastic,Preneoplastic Condition,Condition, Precancerous,Conditions, Precancerous,Precancerous Condition
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration

Related Publications

A Hagiwara, and Y Kokubo, and Y Takesada, and H Tanaka, and S Tamano, and M Hirose, and T Shirai, and N Ito
February 2001, Cancer letters,
A Hagiwara, and Y Kokubo, and Y Takesada, and H Tanaka, and S Tamano, and M Hirose, and T Shirai, and N Ito
March 1995, Cancer research,
A Hagiwara, and Y Kokubo, and Y Takesada, and H Tanaka, and S Tamano, and M Hirose, and T Shirai, and N Ito
January 1981, Virchows Archiv. A, Pathological anatomy and histology,
A Hagiwara, and Y Kokubo, and Y Takesada, and H Tanaka, and S Tamano, and M Hirose, and T Shirai, and N Ito
January 2016, Journal of toxicology and environmental health. Part A,
A Hagiwara, and Y Kokubo, and Y Takesada, and H Tanaka, and S Tamano, and M Hirose, and T Shirai, and N Ito
November 2001, Journal of agricultural and food chemistry,
A Hagiwara, and Y Kokubo, and Y Takesada, and H Tanaka, and S Tamano, and M Hirose, and T Shirai, and N Ito
October 1991, Carcinogenesis,
A Hagiwara, and Y Kokubo, and Y Takesada, and H Tanaka, and S Tamano, and M Hirose, and T Shirai, and N Ito
May 2008, Journal of bioscience and bioengineering,
A Hagiwara, and Y Kokubo, and Y Takesada, and H Tanaka, and S Tamano, and M Hirose, and T Shirai, and N Ito
November 1990, Cancer letters,
A Hagiwara, and Y Kokubo, and Y Takesada, and H Tanaka, and S Tamano, and M Hirose, and T Shirai, and N Ito
February 2003, Human & experimental toxicology,
A Hagiwara, and Y Kokubo, and Y Takesada, and H Tanaka, and S Tamano, and M Hirose, and T Shirai, and N Ito
June 2000, Carcinogenesis,
Copied contents to your clipboard!